Everand Logo

Welcome to Everand!

  • STAT

    Opinion: First ladies can help lead the fight against HIV/AIDS

    Women need to lead the fight against HIV/AIDS. First ladies have a unique platform to do that and can also amplify all women's voices.
    by Agnes Mahomva May 29, 2019 3 minutes
    Graça Machel, the former first lady of South Africa, gives a speech during the Annual Global Business Coalition on HIV/AIDS Excellence Gala reception in 2006 in London.

    Complacency, the United Nations warned in its latest report on AIDS, constitutes a grave threat to decades of progress against HIV. The report, a self-proclaimed “wake-up call,” was directed at the entire global health community. But its message is particularly urgent and personal for African women, who bear the brunt of the HIV pandemic but who are also in the vanguard of the fight against it.

    In sub-Saharan Africa, women between the ages of 15 and 24 years represent just 10% of the population, but 25% of . In West and Central Africa, are among young women. Access to the antiretroviral drugs that fight HIV, which pregnant and breastfeeding women need to stay healthy and protect their babies from infection, has over the past three years.

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
    To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.
    STAT1 min read
    USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
    With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
    Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.

    Related